I doubt it. There are too many sources competing and driving prices down. Once a vendor figures out the product, all they can compete on is price.
They could easily make a few small tweaks to stand out, but nobody seems to bother. Oh well, still cheap.
Also, tons of new GLP1 meds are coming...